Thermo Fisher Scientific Inc. stock underperformed its rival TMO while serving customers across the Americas.
2 reports, 2 independent
Updated Jun 15
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Thermo Fisher Scientific Inc. stock underperformed its rival TMO while serving customers across the Americas.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Thermo Fisher Scientific Inc.
multinational company providing scientific instrumentation
Nothing else this week.
-
Americas
North America and South America taken together as a single continent or landmass
Related events
- Thermo Fisher Scientific Inc., based in Waltham, MA, is facing stock performance issues compared to the S&P 500, with analyst coverage available.
- Thermo Fisher Scientific Inc. and iSpecimen are two healthcare companies that are currently competing for market share.
- Liberty Capital bought a new stake in TMO stock.
- Thermo Fisher Scientific Inc. filed required reports with the SEC on June 16, 2026, influenced by analyst reports from Morgan Stanley.
- Qiagen and Thermo Fisher Scientific Inc. were compared based on financial metrics on September 15, 2026.